Dr. Jeeshan Chowdhury, Founder & CEO of Journey Colab, discusses their contrarian approach to psychedelic drug development, focusing on developing a synthetic form of mescaline. They also emphasize the importance of incorporating psychological and community support in addiction treatment. The podcast explores challenges within capitalist structures, significance of psychedelic research, duration of the psychedelic experience, integrating therapy into rehab centers, and plans for rolling out trials for safe delivery of psychedelic therapies.